ischemia and Western blot analysis from tissue harvested at 16, 24, and 72 h after ischemia. Western blots showed that bcl-x long is the predominant form of bcl-x protein expressed in both normal and ischemic brain. Both bcl-2 and bcl-x-Iong mRNA were expressed in CA I, CA3, and the molecular layer of the dentate after ischemia. However, bcl-2 and bcl-x protein were expressed only in CA3 and dentate. Thus, while bcl-2 and bcl-x-Iong mRNA were expressed in both surviving and dying neurons, their proteins were expressed in neurons destined to survi ve. These results support potential roles for these two apoptosis suppressor proteins in promoting survival after cere bral ischemia. Key Words: Apoptosis-Bcl-2-Bcl-x Ischemia-Rat. sopp et aI., 1993; Batistatou et aI., 1993; Kane et aI., 1993) .
In the central nervous system, bcl-2 is expressed in a large population of neurons during embryonic develop ment (LeBrun et aI., 1993; Novack and Korsmeyer, 1994) , but levels are greatly reduced or undetectable in the majority of postmitotic central nervous system (eNS) neurons of adult brains (Merry et aI., 1994) . However, bcl-2-deficient mice exhibited normal development and maintenance of the eNS (Veis et aI., 1993) . These find ings suggest that other genes may also be important in controlling cell death in the eNS. One of the candidates is bcl-x, a newly isolated gene with significant homology to bcl-2. This alternative splicing of the gene produces at least three proteins: bcl-x-long (bcl-x-l), bcl-x-(3, and bcl-x-short (bcl-x-s). The bcl-x-l form promotes cell sur vival. BcI-x-(3 shares the anti-apoptotic effects of bcl-x-l and is identical to bcl-x-l, although the hydrophobic tail region of bcl-x-(3 is missing (Gonzalez- Garcia et aI., 1995) . The bcl-x-s form blocks bcl-2 function and pro motes cell death. Only bcl-x-l and bcl-x-(3 have been readily detected in adult eNS. Both of these proteins suppress apoptotic death in neurons (Boise et aI., 1993; Gottschalk et aI., 1994; Gonzalez-Garcia et aI., 1995) .
Moreover, bcl-x-deficient mice exhibited extensive ap optotic cell death during the development of eNS and other systems (Motoyama et aI., 1995) .
Our group and others have recently shown that bcl-2 Bcl-2 AND Bcl-x EXPRESSION AFTER ISCHEMIA 3 immunoreactIvIty was induced in sublethally injured neurons following cerebral ischemia (Shimazaki et aI., 1994; Chen et aI., 1995a; Krajewski et aI., 1995) , sug gesting that bc1-2 may be an inducible endogenous neu roprotectant in the adult brain. To further address this hypothesis, we studied the transcriptional and transla tional expression of bc1-2 and bc1-x genes in a rat model of transient global ischemia, in which delayed neuronal cell death occurred in the hippocampal CAl region. It has been suggested that apoptosis is involved in this process (MacManus et aI., 1993; Kihara et al., 1994; Nitatori et aI., 1995) .
METHODS

Animal model
Global ischemia was induced in isoflurane-anesthetized rats using the four-vessel method described by Pulsinelli (Pulsinelli et aI., 1982) with modifications. Male Sprague-Dawley rats (300-350 g) were ventilated with 1.5% isoflurane in a mixture of 25% O2 and 73.5% N20 (vol/vol). The left femoral artery was cannulated for blood pressure monitoring or blood gas and glucose sampling. Rectal temperature was continuously moni tored and kept at 37-37.5°C with a heating pad and lamp. Brain temperature was monitored by a 29-Ga thermocouple im planted in the left striatum and allowed to decline spontane ously from 36.2 ± 0.1 to 34.2 ± 0.5°C during ischemia. Within 5-8 min of reperfusion, brain temperature returned to preisch emia range in all animals. Animals were placed in a stereotaxic frame, and both vertebral arteries were coagulated and tran sected at the level of the junction of first and second cervical vertebrae. The bilateral common carotid arteries (CCAs) were then exposed. Bilateral external carotid arteries were ligated and the anesthesia was discontinued. Then, 3 min later, CCAs were occluded with microvascular clips for 15 min under con tinuous monitoring of the electroencephalograph, (EEG). The EEG became isoelectric in all rats studied within lO s following CCAs occlusion. At variable time points following completion of ischemia, animals were killed according to the experimental protocols.
Northern blot analysis
Specificity of the bcl-2 and bcl-x-I oligonucleotide probes was examined by Northern blot analysis. Hippocampal and cortical total RNA were extracted from normal brains and from brains subjected to 15 min ischemia followed by 24 h of reper fusion (n = 3 rats per sample). Then, 20 /-lg RNA/lane was for Northern blot analysis. Subsequently, mRNA was trans ferred to nylon filters and 40 mer antisense oligodeoxy nucleotides (Biosynthesis Inc., Dallas, TX, U.S.A.) were con structed to be complementary to the regions of each gene shown in Fig. 1 . A BLAST search of the Genbank database revealed no other homologous genes. The sequences used for bcl-2 was 5' -CACTGAATGCTCTCCGGTACCG CAGTTCAAACTCATCGCC-3' (bcl-2 oligo) ( Fig. 1 ) and for bcl-x-Iong was 5'-GGTGGTCATTCAGGTAGGTGGC CATCCAACTTGCAATCCG-3' (bcl-x oligo). Oligodeoxy nucleotides were 3' end-labeled with 40 /-lCi [32p]dATP (spe cific activity > 106 Cilmol) using terminal deoxynucleoti dyltransferase (GIBCO BRL, Grand Island, NY, U.S.A.). Unincorporated nucleotides were separated by P-6-sephorose columns. The labeled probe was denatured by heat and hybrid ized to the filters at 42°C overnight. The washing procedure was performed under high stringency conditions in 2 x sodium! sodium citrate (SSC) buffer/O.! % sodium diodecyl sulfate (SDS) (45 min for three times, 52°C). Membranes were then exposed to Kodak X-OMAT AR films (Eastman Kodak Com pany, Rochester, NY, U.S.A.) using intensifier screens at -80°C for 72 h. Autoradiogram signals were quantified by a gel densitometric scanning program using an MCID image analysis system (St. Catharine's, Ontario, Canada). To control for variation in the amount of RNA in different samples, all blots were rehybridized with an oligonucleotide probe (5' ACGGTATCTGATCGTCTTCGAACC-3') corresponding to 18 S RNA. The original probe was stripped off in a solution containing 0.1 x SSC and 0.5% SDS at 100°C for 15 min. All densitometric values for bcl-2 and bcl-x-l were normalized to values for 18 S RNA obtained on the same lane.
In situ hybridization
Rats used for in situ hybridization were anesthetized with 4% chloral hydrate and decapitated 2, 4, 8, 24, and 72 h following 15 min of global ischemia (n = 3 per group). Brains were rapidly removed, frozen in 2-methylbutane at -30°C and stored at -80°C. Sections (20 /-lm) were cut on a cryostat at -20°C, collected on Probe-On Slides (Fisher Biotech, Pittsburgh, P A, U.S.A.), and processed for in situ hybridization using the method previously described (Chen et a!., 1995b) . Briefly, oli godeoxynucleotide probes were labeled with [135S]-dATP us ing terminal deoxynucleotidyltransferase and hybridized (1 x 106 cpm!ml) at 42°C for 18 h with the slides. After hybridiza tion, sections were rinsed in 1 x SSC (150 mM sodium chloride and 15 mM sodium citrate, pH 7.4) at 55°C for 60 min with several changes of 1 x SSC, dehydrated, and exposed to a Kodak SB-5 film for 3 weeks. Control and ischemic brain slides were hybridized together and developed on the same film. Relative changes in mRNA expression were then quanti fied by determining the ratio of the optical density of the speci fied regions in ischemic brains versus controls using the MCID system. Cellular localization was evaluated by coating slides with Kodak NTB-2 emulsion. Sections were exposed at 4°C for 5 weeks, developed in D-19, and counterstained with cresyl violet.
Western blot analysis
Western blot analysis was performed to verify the specificity and efficiency of the monoclonal bcl-2 (Dako Co., Carpenteria, CA, U.S.A.) and bcl-x (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) antibodies used in these studies. The peptides used to produce these antibodies are shown in Fig. 1 . Rats were killed at 16,24, and 72 h following 15 min ischemia (n = 3 per group). Hippocampi were dissected, homogenized, and lysed.
Then, 40 f.Lg protein samples from each brain were loaded onto a 12% SDS-polyacrylamide gel. Western blots were performed as described previously (Sambrook et aI., 1989) , using the che miluminescent detection system (Clontech, Palo Alto, CA, U.S.A.). The transferred polyvinylidene difluride (PVDF) membrane was incubated in bcl-2 or bcl-x antibody at a dilu tion of I :200 at 4°C overnight, followed by washing procedures and secondary antibody reactions. Chemiluminescent substrate, 25 mM (Clontech Laboratories, Palo Alto, CA, U.S.A.) was applied to the side of the membrane containing the blotted proteins. The blot was wrapped in plastic wrap and exposed to a Kodak X-OMAT film.
Immunocytochemistry
Rats were given 100 Ulkg heparin i.p. and anesthetized with 4% chloral hydrate. Five min later, they were perfused with 4% paraformaldehyde in 0.1 M phosphate-buffered sarine (PBS) (pH 7.4) at 4,8, 16, 24, or 72 h following 15 min ischemia (n = 3 per group). Brains were removed, postfixed for 4 h, sec tioned at 50 f.Lm on a vibratome, and processed for immuno cytochemistry staining for bcl-2 and bcl-x (I: 100 dilution), using the avidin-biotin-horseradish peroxidase technique pre viously described (Chen et aI., 1995a) . As a control, alternate sections were incubated in the absence of primary antibodies. 
RESULTS
Northern blot analysis
Bcl-2 and bcl-x-l oligonucleotide probes were hybrid ized in a single band at -2.5 and 2.7 kb, respectively, with both control and ischemic brain samples (Fig. 2) .
Both bcl-2 and bcl-x-l mRNAs were present at low levels in control brain but were increased in ischemic samples.
Bcl-2 expression was increased 1.89-fold in the cortex and 2.49-fold in the hippocampus, compared to nonisch emic brain. Bcl-x expression was also increased 1.95fold in the cortex and 2.97-fold in the hippocampus, compared to nonischemic brain.
In situ hybridization
In Emulsion-coated slides revealed that silver grains oc curred predominantly in neuronal elements (Fig. 3C ).
Western blot analysis
As shown in the representative Western blot in Fig.   4A , anti-human bcl-2 antibody detected a band at -26 kDa, the predicted size for the bcl-2 protein. Bcl-2 pro tein was present at a very low level in control samples, but the protein level was elevated in ischemic samples. Histological studies revealed that few morphological changes occurred in the hippocampus at 24 h after isch emia, but the majority (>95%) of neurons in the CAl disappeared or showed pyknotic changes at 72 h.
DISCUSSION
Because energy failure is a common characteristic of necrotic cell death, one would assume that new gene expression and apoptosis do not occur and would not be an important mechanism of cell death in ischemia. How ever, a number of studies have suggested that new gene expression is involved in the delayed neuronal death of CAl hippocampal neurons after global ischemia. Energy stores are rapidly restored after global ischemia (Shimizu, et aI., 1993) . Protein synthesis inhibitors pre vent delayed death of CAl neurons (Goto et aI., 1990; Shigeno et aI., 1990; Papas et aI., 1993) . DNA fragmen tation has been detected; this suggests that endonucleases are activated (MacMannus et aI., 1993; Kihara et aI., 1994; Nitatori et aI., 1995) . Some of the histological attributes of apoptosis are present (Nitatori et aI., 1995) , although this was not supported by some other studies (Deshpande et aI., 1992) . Thus, since cell death after ischemia may require new gene expression and have some of the attributes of apoptosis, it is not unrealistic to hypothesize that genes in the apoptotic family could play a role in determining the fate of ischemic neurons.
Bcl-2 and bcl-x are two well-characterized genes that regulate apoptotic cell death in mammals. Basal expres sion of bcl-2 and bcl-x-l mRNA was detectable, although at low levels, in control nonischemic brains. Several dif ferent bcl-2 transcripts have been described in rodents;
these all appear to have the same open reading frame and encode the same protein (Castren et aI., 1994) . Differ ences in transcript length attributable to polymorphisms in the nontranslated region of the bcl-2 mRNAs appear to be tissue, species and strain specific. The bcl-2 mRNA detected by NO I1 hern analysis in this study was similar in size to a bcl-2 transcript fond in mouse brain and Wistar rat thymus (Negrini et aI., 1987; Castren et aI., 1994) . These results also confirm the observation that a short mRNA transcript is the predominant bcl-2 mRNA expressed in Sprague Dawley extragonadal tissues, including brain (Tilly et aI., 1995) , although multiple transcripts have been described in the Wistar rat (Castren et aI., 1994) .
In contrast to mRNA, bcl-2 and bcl-x-l protein were differentially expressed in control brains. While bcl-2 immunoreactivity was very low in the Western blot analysis and hardly detected in immunocytochemical sections, bcl-x-l was present at a much higher level in the Western blot and was readily detectable with immuno cytochemistry in many cortical and some hippocampal neurons in normal controls. These observations are con sistent with previous findings that bcl-x-l, but not bcl-2, protein is expressed in a significant amount in the normal adult rodent brain (Boise et aI., 1993; Merry et aI., 1994) .
Furthermore, bands at the appropriate locations for bcl
x-s and bcl-x-� were not detectable in Western blots, suggesting that neither bcl-x-� nor bcl-x-s is a major product of the bcl-x genome in either control or ischemic rat brain. These results are in keeping with the observa tion that bcl-x-l mRNA is the major transcript of bcl-x expressed in the adult mouse brain (Gonzalez- Garcia et aI., 1995) .
Results show that bcl-2 and bcl-x-l mRNA were in duced mainly in the hippocampus with similar expres sion patterns following global ischemia. The CAl pyra-midal cell layer exhibited the highest expression signals for both mRNAs, followed by the granular cell layers of the DG and the CA3 pyramidal layer. Induction of both mRNAs in CAl neurons was more persistent (at least 48 h) than was their induction in CA3 neurons and the DG (24 h). Finally, induction for both genes in CAl neurons peaked at 24 h and then decreased below basal level at 72 h, coinciding with the histologic death of these neurons.
Immunocytochemistry studies revealed a somewhat different pattern for bcl-2 and bcl-x-l protein accumula tion compared to mRNA expression in ischemic brains.
Both bcl-2 and bcl-x-l immunoreactivity were detected at a high level in CA3 pyramidal neurons and in many DG granule cells at 24 or 72 h following ischemia. But while expression of both bcl-2 and bcl-x-l mRNA was induced in CAl neither bcl-2 nor bcl-x protein was expressed there. These results are in accordance with the observa tions that lethal ischemia inhibits bcl-2 expression in CAl in gerbil global ischemia (Shimazaki et aI., 1994) and that neither bcl-2 protein nor bcl-x protein is ex pressed in CAl after cardiac arrest in rats (Krajewski et aI., 1995) . The discrepancy between in situ data and im munocytochemistry results suggests that translation of bcl-2 and bcl-x mRNA is blocked in CAl after ischemia.
This result is not surprising, since inhibition of protein synthesis is a well-known consequence of ischemia (Vass et aI., 1988; Kiessling et aI., 1993) . Thus, bcl-2 and bcl-x protein are not expressed in CAl , and apoptotic death may be unopposed.
But, if protein synthesis is inhibited, how could apop tosis effector proteins be expressed? The answer appears to be that selective proteins are translated in ischemic neurons fated for delayed neuronal death. For example, the apoptosis effector gene p53 is expressed in ischemic neurons within an infarction after middle cerebral artery occlusion (Chopp et ai., 1992) . Bax, an apoptosis effec tor protein, is also expressed prior to death of CAl after ischemia (Krajewski et ai., 1995) . We have recently shown that cyclooxygenase 2 protein, which could be an apoptosis effector via its generation of oxygen-free radi cals, is expressed in CAl neurons 24 h after global isch emia (Nakayama et aI., 1995) . The efficacy of protein synthesis inhibitors in preventing delayed neuronal death after global ischemia also suggests that translation of these selective proteins must occur in order to result in delayed neuronal death in the CAl (Goto et ai., 1990; Shigeno et ai., 1990; Papas et ai., 1993) . Thus, severely injured neurons may' 'selectively" translate adverse pro teins using their partially functional protein synthesis ca pacity. In such circumstances, the adverse gene products in these neurons may be dominant and mediate cell death. Therefore, further experiments designed to study expression of the functionally balanced genes such as bcl-2/Bax or bcl-x-l/bcl-x-s in the same neuronal popu lations may help us understand the role of these genes in ischemic injury.
Bcl-2 immu q oreactivity was induced in glial cells in the hippocampal white matter 72 h after ischemia. Bcl-2 positive glial cells in the middle region of the white matter are astrocytes, since they reacted positively with the glial filament acidic protein antibody; however, the glial cells localized adjacent to the CA I region were mainly microglia, since they reacted with the OX-6 an tibody (data not shown). Thus, both microglia and astro cytes expressed bcl-2 protein. This was consistent with our previous findings that bcl-2 immunoreactivity was induced in glia in the border zone of infarction following focal ischemia (Chen et ai., 1995a) . The significance of this bcl-2 induction in glial cells is unclear. Merry re ported that microglia comprise the major cell population expressing bcl-2 in the adult brain (Merry et ai., 1994) ,
suggesting that bcl-2 may be important for the mainte nance of these cells after development. It has been shown that microglia are activated following cerebral ischemia (Morioka et aI., 1993; Kato et ai., 1994; Lehrmann et aI., 1995) and generate oxygen-derived free radicals (Chao et ai., 1992) . The time for glial bcl-2 induction in this study is comparable to the reported time course for glial activation after global ischemia (Kato et aI., 1994) .
Therefore, by reducing the intracellular generation of oxygen-free radicals, bcl-2 protein may protect activated microglia from their endogenous oxidants (Hockenbery et aI., 1993; Kane et ai., 1993; Veis et aI., 1993) . Further studies are required to address these issues.
The major finding of this study is that expression of both bcl-2 and bcl-x-l mRNA and protein is increased in CA3 after global ischemia, a region that is ischemic, yet survives. Thus, expression of bcl-2 and bcl-x may pro mote survival of these ischemic neurons. The ability of bcl-2 and bcl-x-l gene products to inhibit neuronal ap optosis in vitro is well documented, but the mechanism for this protection is unclear. Kane et al (1995) showed that bcl-2 expression may prevent necrotic neuronal death as well as apoptosis. This observation suggests that, instead of inhibiting a cellular death program di rectly, bcl-2 may modulate a generalized cellular process (such as generation of oxygen-derived free radicals) that may contribute to either apoptotic or necrotic death (Kane et aI., 1995) . Two observations support a role for bcl-2 as an endogenous neuroprotectant in vivo: overex pression of bcl-2 via an amplicon Herpes simplex vector decreased infarction, although marginally, after focal ischemia (Linnik et ai., 1995) ; and a transgenic mouse that overexpresses bcl-2 had significantly smaller infarc tion after middle cerebral artery occlusion than did wild type controls (Martinou et aI., 1994) .
In summary, this study demonstrated a differential ex pression pattern for bcl-2 and bcl-x-l at their transcrip tional and translation levels in the rat brain subjected to transient global ischemia. While bcl-2 and bcl-x-l mRNA were expressed in both surviving and dying neurons, their proteins were expressed primarily in neurons des tined to survive. These results support a possible neuro protective role for these two apoptosis suppressor genes in cerebral ischemic injuries. However, in order to con firm that expression of these proteins after cerebral isch emia promotes survival rather than being an epiphenom enon, further studies, in which synthesis of these proteins is specifically altered after ischemia, are required.
ADDENDUM
After submission of this article, we published the re sults of a study of the expression of the bcl-2 family protein Bax after global ischemia in rat (Chen et aI., 1996) . The proapoptotic protein Bax was primarily ex pressed in CAl neurons which die after ischemia. We also colocalized the expression of Bax with the bcl-2 protein and found that bcl-2 was expressed in CA3 neu rons which survive after ischemia, as was reported here.
